These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
651 related items for PubMed ID: 16801462
21. Infarct characterization and quantification by delayed enhancement cardiac magnetic resonance imaging is a powerful independent and incremental predictor of mortality in patients with advanced ischemic cardiomyopathy. Kwon DH, Asamoto L, Popovic ZB, Kusunose K, Robinson M, Desai M, Marwick TH, Flamm SD. Circ Cardiovasc Imaging; 2014 Sep; 7(5):796-804. PubMed ID: 25085923 [Abstract] [Full Text] [Related]
22. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Kwong RY, Korlakunta H. Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157 [Abstract] [Full Text] [Related]
23. Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients. Golia G, Anselmi M, Tinto M, Cicoira M, Rossi A, Marino P, Zardini P. Cardiologia; 1999 Dec; 44(12):1029-37. PubMed ID: 10687252 [Abstract] [Full Text] [Related]
24. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, Leyva F. J Am Coll Cardiol; 2007 Jul 17; 50(3):243-52. PubMed ID: 17631217 [Abstract] [Full Text] [Related]
25. Comparison of diagnostic and prognostic value of different electrocardiographic criteria to delayed-enhancement magnetic resonance imaging for healed myocardial infarction. Krittayaphong R, Maneesai A, Chaithiraphan V, Saiviroonporn P, Chaiphet O, Udompunturak S. Am J Cardiol; 2009 Feb 15; 103(4):464-70. PubMed ID: 19195503 [Abstract] [Full Text] [Related]
26. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. Nijveldt R, Beek AM, Hofman MB, Umans VA, Algra PR, Spreeuwenberg MD, Visser CA, van Rossum AC. J Cardiovasc Magn Reson; 2007 Feb 15; 9(5):765-70. PubMed ID: 17891613 [Abstract] [Full Text] [Related]
27. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials. Yap YG, Duong T, Bland JM, Malik M, Torp-Pederson C, Køber L, Connolly SJ, Gallagher MM, Camm AJ. J Hypertens; 2007 Feb 15; 25(2):307-13. PubMed ID: 17211237 [Abstract] [Full Text] [Related]
28. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C. Am Heart J; 2009 Mar 15; 157(3):541-7. PubMed ID: 19249426 [Abstract] [Full Text] [Related]
29. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP. Heart; 2011 Dec 15; 97(23):1951-6. PubMed ID: 21917670 [Abstract] [Full Text] [Related]
30. Infarct characteristics by CMR identifies substrate for monomorphic VT in post-MI patients with relatively preserved systolic function and ns-VT. Yalin K, Golcuk E, Buyukbayrak H, Yilmaz R, Arslan M, Dursun M, Bilge AK, Adalet K. Pacing Clin Electrophysiol; 2014 Apr 15; 37(4):447-53. PubMed ID: 24215211 [Abstract] [Full Text] [Related]
31. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Larose E, Proulx G, Voisine P, Rodés-Cabau J, De Larochellière R, Rossignol G, Bertrand OF, Tremblay JP. Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):120-7. PubMed ID: 19859959 [Abstract] [Full Text] [Related]
32. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy. Takeda K, Matsumiya G, Matsue H, Hamada S, Sakaki M, Sakaguchi T, Fujita T, Sawa Y. J Thorac Cardiovasc Surg; 2008 Dec 01; 136(6):1514-21. PubMed ID: 19114200 [Abstract] [Full Text] [Related]
33. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Watanabe E, Abbasi SA, Heydari B, Coelho-Filho OR, Shah R, Neilan TG, Murthy VL, Mongeon FP, Barbhaiya C, Jerosch-Herold M, Blankstein R, Hatabu H, van der Geest RJ, Stevenson WG, Kwong RY. Circ Cardiovasc Imaging; 2014 Nov 01; 7(6):887-894. PubMed ID: 25287527 [Abstract] [Full Text] [Related]
34. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J. Eur Heart J; 2009 Jun 01; 30(12):1440-9. PubMed ID: 19346229 [Abstract] [Full Text] [Related]